HGERS
GANX icon

Householder Group Estate & Retirement Specialist’s Gain Therapeutics GANX Stock Holding History

Householder Group Estate & Retirement Specialist’s Portfolio GANX Stock Details GANX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-2,500
Closed -$8.2K – 1209
2023
Q3 		$8.2K Buy
+2,500
New +$9.48K ﹤0.01% 835

Other funds holding GANX

GC
Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
PCM
Prelude Capital Management New York $1.31B AUM 62.01% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Householder Group Estate & Retirement Specialist's GANX Position: Q4 2023 in Review

Householder Group Estate & Retirement Specialist sold out of Gain Therapeutics (GANX) in Q4 2023, closing a stake of 2,500 shares — an estimated $8.2K sold.

Householder Group Estate & Retirement Specialist first reported a position in GANX in Q3 2023 and held it in 1 quarter. The position peaked at $8.2K in Q3 2023. 24 funds tracked by Wall St. Rank hold GANX as of Q4 2023.

  • Householder Group Estate & Retirement Specialist reported no remaining Gain Therapeutics position as of Q4 2023 after selling out during the quarter.
  • Householder Group Estate & Retirement Specialist sold 2,500 Gain Therapeutics shares in Q4 2023, an estimated $8.2K.
  • Householder Group Estate & Retirement Specialist first reported a position in Gain Therapeutics in Q3 2023 and held it in 1 quarter.
  • Householder Group Estate & Retirement Specialist's Gain Therapeutics position peaked at $8.2K in Q3 2023.
  • 24 funds tracked by Wall St. Rank held Gain Therapeutics as of Q4 2023.

Based on Householder Group Estate & Retirement Specialist's 13F filing for Q4 2023, filed 23 Jan 2024.